SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Hospira, Inc. And Encourages Investors T...
10 Fevereiro 2015 - 4:40PM
Business Wire
The securities litigation law firm of Brower Piven, A
Professional Corporation, has commenced an investigation into
possible breaches of fiduciary duty and other violations of state
law by the Board of Directors of Hospira, Inc. (“Hospira” or the
“Company”) (NYSE: HSP) relating to the proposed buyout of the
Company by Pfizer Inc. (“Pfizer”).
On February 5, 2015, Hospira and Pfizer announced the signing of
a definitive agreement pursuant to which Pfizer will acquire
Hospira in a transaction valued at approximately $17 billion. Under
the terms of the transaction, Hospira shareholders are anticipated
to receive $90.00 in cash for each share of Hospira common stock
held. The transaction is expected to close in the second half of
2015, though Hospira shareholders will most likely be asked to vote
on the transaction well before that time.
The firm’s investigation seeks to determine, among other things,
whether the Company’s Board of Directors failed to satisfy their
duties to shareholders, including whether the Board adequately
pursued alternatives to the acquisition and whether the Board
obtained the best price possible for the Company’s shares of common
stock.
If you currently own common stock of Hospira and would like to
learn more about the investigation being conducted by Brower Piven,
without cost or obligation to you, please visit our website at
http://www.browerpiven.com/currentinvestigations.html. You may also
request more information by contacting Brower Piven either by email
at hoffman@browerpiven.com or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in
litigating securities and other class action cases and have been
advocating for the rights of shareholders since the 1980s.
Brower Piven, A Professional CorporationCharles J. Piven,
410-415-66161925 Old Valley RoadStevenson, Maryland
21153hoffman@browerpiven.com
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre da New York Stock Exchange bolsa de valores: 0 artigos recentes
Mais Notícias de Hospira